Laurantis Pharma, Ark Therapeutics Sign Manufacturing Agreement

15.10.2012 - UK Ark Therapeutics has been selected to manufacture and supply Lymfactin to Laurantis Pharma under a conditional agreement announced today by the Finland-based companies. The...